Brookdale Senior Living (BKD) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
15 Dec, 2025Executive summary
Q4 and full-year 2024 RevPAR and adjusted EBITDA exceeded guidance, with strong operational and financial progress driven by occupancy gains, strategic acquisitions, and portfolio optimization.
Weighted average occupancy grew 140 basis points year-over-year, with Q4 occupancy at 79.4% and full-year at 78.6%.
Strategic focus on profitable occupancy, associate retention, and resident satisfaction, despite mid-year occupancy challenges from third-party referral disruptions.
Major lease amendments, acquisitions, and dispositions increased owned real estate, reduced lease exposure, and improved cash flow.
Net loss improved by nearly 8% in Q4, with net cash from operating activities up 54% and adjusted free cash flow up 46% year-over-year.
Financial highlights
Q4 2024 consolidated revenue was $744.4M, up 3.9% year-over-year; full-year revenue was $2.97B, up 4.0%.
Q4 adjusted EBITDA was $98.5M, up 15.5% year-over-year; full-year adjusted EBITDA was $386.2M, up 15.1%.
Adjusted free cash flow improved nearly 40% year-over-year, with Q4 at $(11.5)M and full-year at $(29.5)M.
Annualized leverage ended at 10.4x (9.9x normalized), with $389M in liquidity at year-end.
ONOI per available unit is 8% above 2019 levels despite lower occupancy.
Outlook and guidance
2025 guidance: RevPAR growth of 4.75%-5.75% and adjusted EBITDA of $430-$445M, representing 11%-15% year-over-year growth.
Guidance reflects the October 2025 disposition of 55 Ventas non-renewal communities and incremental $3M facility operating expense for new ERP system.
2025 non-development capital expenditures projected at $175M–$180M.
Expectation for continued positive adjusted free cash flow in 2025, with further improvement in occupancy and expense management.
RevPOR growth expected to moderate in 2025 due to lower in-place rate increases and lower acuity move-in trends.
Latest events from Brookdale Senior Living
- Operational focus, targeted CapEx, and market-driven M&A support growth amid strong demand.BKD
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Record 2025 EBITDA and occupancy set stage for robust 2026 growth and portfolio streamlining.BKD
Q4 202519 Feb 2026 - Q2 saw 20% Adjusted EBITDA growth, higher occupancy, but a wider net loss on higher costs.BKD
Q2 20241 Feb 2026 - 2026 targets $502–$516M Adjusted EBITDA and 8–9% RevPAR growth, led by operational transformation.BKD
Investor Day 202630 Jan 2026 - Q3 2024 delivered 15% EBITDA growth, higher occupancy, and $610M in acquisitions pending.BKD
Q3 202415 Jan 2026 - Strategic acquisitions, strong occupancy, and HealthPlus expansion drive positive 2025 outlook.BKD
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - Accelerating occupancy, strong cash flow, and innovation position for sustained growth.BKD
Barclays 27th Annual Global Healthcare Conference26 Dec 2025 - Contested director election, performance-based pay, and auditor ratification headline the 2025 proxy.BKD
Proxy Filing1 Dec 2025 - Ortelius seeks to overhaul board leadership to address underperformance and drive value creation.BKD
Proxy Filing1 Dec 2025